The push to merge wireless rivals Sprint and T-Mobile is taking longer than expected and the companies likely will delay news until mid or late November, according to a published report.
Bloomberg, in an online post Thursday, October 19, said the companies had hoped to announce news late this month when they normally would report quarterly updates on their financial results and customer counts.
That timetable “now appears unlikely,” said Bloomberg’s report, which cited sources familiar with the talks.
“If a deal can’t be signed by then, the companies will probably wait two or three more weeks after disclosing quarterly results to announce an agreement,” Bloomberg said, citing its sources.
Sprint chairman Masayoshi Son has wanted to acquire T-Mobile since shortly after gaining control of Sprint in 2013 through a US$21.6 billion transaction. Son is CEO of Tokyo-based SoftBank that owns more than 80% of Sprint’s shares.
T-Mobile US is roughly two-thirds owned by Deutsche Telekom, which had agreed in 2011 to sell its US wireless carrier to AT&T. Federal regulators blocked that US$39 billion deal citing a preference for four national wireless carriers to three.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas